Home >> Pharmaceuticals >> Food & Beverage >>

Maruho Co., Ltd. - Product Pipeline Review - 2015

Published: Aug-2015 | Format: PDF | Global Markets Direct | Number of pages: 41 | Code: MRS - 35158

Maruho Co., Ltd. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Maruho Co., Ltd. - Product Pipeline Review - 2015’, provides an overview of the Maruho Co., Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Maruho Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Maruho Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Maruho Co., Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Maruho Co., Ltd.’s pipeline products

Reasons to buy

- Evaluate Maruho Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Maruho Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Maruho Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Maruho Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Maruho Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Maruho Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Maruho Co., Ltd. Snapshot 5
Maruho Co., Ltd. Overview 5
Key Information 5
Key Facts 5
Maruho Co., Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Maruho Co., Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Combination Treatment Modalities 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
Maruho Co., Ltd. - Pipeline Products Glance 13
Maruho Co., Ltd. - Late Stage Pipeline Products 13
Pre-Registration Products/Combination Treatment Modalities 13
Phase III Products/Combination Treatment Modalities 14
Maruho Co., Ltd. - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Maruho Co., Ltd. - Drug Profiles 16
benzoyl peroxide 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
betamethasone valerate + maxacalcitol 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
ozenoxacin 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
amenamevir 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
GK-664S 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
pefcalcitol 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
propranolol hydrochloride 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
lanoconazole 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
M-1170 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
M-7040 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
TA-7906 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Maruho Co., Ltd. - Pipeline Analysis 29
Maruho Co., Ltd. - Pipeline Products by Target 29
Maruho Co., Ltd. - Pipeline Products by Route of Administration 30
Maruho Co., Ltd. - Pipeline Products by Molecule Type 31
Maruho Co., Ltd. - Pipeline Products by Mechanism of Action 32
Maruho Co., Ltd. - Recent Pipeline Updates 33
Maruho Co., Ltd. - Dormant Projects 36
Maruho Co., Ltd. - Company Statement 37
Maruho Co., Ltd. - Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Appendix 40
Methodology 40
Coverage 40
Secondary Research 40
Primary Research 40
Expert Panel Validation 40
Contact Us 40
Disclaimer 41

List of Tables
Maruho Co., Ltd., Key Information 5
Maruho Co., Ltd., Key Facts 5
Maruho Co., Ltd. - Pipeline by Indication, 2015 7
Maruho Co., Ltd. - Pipeline by Stage of Development, 2015 8
Maruho Co., Ltd. - Monotherapy Products in Pipeline, 2015 9
Maruho Co., Ltd. - Combination Treatment Modalities in Pipeline, 2015 10
Maruho Co., Ltd. - Partnered Products in Pipeline, 2015 11
Maruho Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2015 12
Maruho Co., Ltd. - Pre-Registration, 2015 13
Maruho Co., Ltd. - Phase III, 2015 14
Maruho Co., Ltd. - Phase II, 2015 15
Maruho Co., Ltd. - Pipeline by Target, 2015 29
Maruho Co., Ltd. - Pipeline by Route of Administration, 2015 30
Maruho Co., Ltd. - Pipeline by Molecule Type, 2015 31
Maruho Co., Ltd. - Pipeline Products by Mechanism of Action, 2015 32
Maruho Co., Ltd. - Recent Pipeline Updates, 2015 33
Maruho Co., Ltd. - Dormant Developmental Projects,2015 36
Maruho Co., Ltd., Other Locations 38
Maruho Co., Ltd., Subsidiaries 39

List of Figures
Maruho Co., Ltd. - Pipeline by Top 10 Indication, 2015 7
Maruho Co., Ltd. - Pipeline by Stage of Development, 2015 8
Maruho Co., Ltd. - Monotherapy Products in Pipeline, 2015 9
Maruho Co., Ltd. - Partnered Products in Pipeline, 2015 11
Maruho Co., Ltd. - Pipeline by Top 10 Target, 2015 29
Maruho Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015 30
Maruho Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015 31
Maruho Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015 32

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing